共 50 条
- [32] Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05): : 1694 - 1700
- [34] Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (07): : 2498 - 2509
- [35] Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness–adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension Osteoporosis International, 2023, 34 : 1075 - 1084
- [37] Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis Calcified Tissue International, 2018, 103 : 50 - 54